Avoiding apoptosis, the naturally-occurring method by which the body rids itself of damaged or unwanted cells, is one way that cancer and Stage 4 Cancer develops and progresses.
Apoptosis is triggered by cell stress, DNA damage, developmental cues, and other signals from within the body. Unfortunately, we commonly see cells in cancer patients diverting this process. And in doing so their cancers are able to survive, continue to develop, and even spread.
In short, the body already has the equipment to rid itself of cancer; so the question is “why are stage 4 cancer patients diverting apoptosis?”
Mutations Bring About Stubborn and Resistant Stage 4 Cancers
Well, let’s consider how apoptosis is triggered. There are two basic ways:
=> From within the cell
=> From outside the cell
For apoptosis to be triggered from within, the process requires a protein, p53. Mutations to the p53 protein gene can cause it to become inactive, thereby preventing normal, healthy apoptosis. This type of mutation is seen in almost 50 percent of all human cancer. Preventing such mutation is a good step toward improving the overall results of treatment.
Stage 4 Cancers Can Dodge the Silver Bullet of Chemotherapy
Chemotherapy and radiation cause DNA damage to cells by affecting their DNA. But, because DNA mutation apoptosis triggers rely on p53, if the p53 is itself mutated, apoptosis may never occur - saving cancer cells from what would be imminent destruction.
There are many clinical studies that show that customary protocols are seeing cancer progressions and recurrences for just this reason. By employing advanced nutritional treatments to prevent p53 oncogene mutation, Envita works hard with patients to help their bodies enjoy normal and healthy apoptosis.
Stage 4 Cancer treatments fail repeatedly when treatment protocols are implemented, which focus on symptoms and effects alone. In reality, these battles are most often won by attacking the causes directly. Our chances of success increase considerably when measures are taken to eliminate deficiencies in nutrition, immunology, and the ability to eliminate toxins.
Launching an Attack on Cancer
It is possible to combine treatments to trigger apoptosis from outside the cell, as well as from inside the cell that do not require p53. In doing so, apoptosis may be achieved in cancer cells that had previously been considered “resistant” to traditional treatments. Envita works vigorously to capitalize and even further this approach and its subsequent results. Attacking apoptosis form outside the cell is essential for stage 4 cancer patients as chemotherapy has usually stopped working.
Envita provides its patients with mitochondria dysfunction support with the necessary nutrients and treatments to reestablish normal healthy function. More than a decade of experience dealing with the most difficult stage 4 cancers has provided insight as to which treatments are most successful in helping the body attack and eliminate cancer cells.
The Better the Treatment – the Better the Result
Envita’s Comprehensive Smart Oncology® (link to Envita cancer home page) program integrates successful oncology combinations with our aggressive natural therapies that affect apoptosis in cancer cells by using tumor destruction methods that actually rely solely on p53. Visit our PPMR process (link to Envita home or PPMR home)or contact us speak to one of our patient-care educators so that we can put an immediate plan in place for you.
